-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Processa Pharma, Maintains $6 Price Target

Benzinga·12/05/2024 11:11:57
Listen to the news
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Processa Pharma (NASDAQ:PCSA) with a Buy and maintains $6 price target.